Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Jack Yongfeng Zhang — FY2025 total compensation $8,309,350

Jack Yongfeng Zhang is Chief Executive Officer, President, Chief Scientific Officer and Director of Amphastar Pharmaceuticals, Inc. (AMPH). The company reported total compensation of $8,309,350 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$950,911
Bonus$329,747
Stock awards$3,301,981
Option awards$3,302,024
Non-equity incentive plan$361,000
Pension and non-qualified deferred compensation
All other compensation$63,687
Total$8,309,350

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Amphastar Pharmaceuticals, Inc. filed April 13, 2026, accession 0001297184-26-000023.

03

Peer context

Peer-group chief executive median$10,957,769
Difference from that median$-2,648,418
Percentile within the disclosed peer group38th
Peers with a disclosed figure16

Medians and percentiles are computed across the peer group Amphastar Pharmaceuticals, Inc. discloses in its own compensation disclosure.

04

The other named executive officers of Amphastar Pharmaceuticals, Inc.

Named executive officerRoleFY2025 total
Jack Yongfeng Zhang this pageChief Executive Officer, President, Chief Scientific Officer and Director$8,309,350
Mary Ziping LuoChief Operating Officer, Chief Scientist and Chairman of the Board of Directors$4,031,078
William PetersChief Financial Officer, Executive Vice President of Finance, Treasurer, President of International Medication Systems, Limited, and Director$3,238,682
Rong ZhouSenior Executive Vice President of Production Center; Executive Vice President of Scientific Affairs and President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.$2,542,634
Jacob LiawatidewiExecutive Vice President of Sales and Marketing and Corporate Administration Center, President of Amphastar France Pharmaceuticals, S.A.S., Corporate Secretary and Director$2,037,856

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Amphastar Pharmaceuticals, Inc. compensation brief.

05

The company page

Jack Yongfeng Zhang's compensation sits inside Amphastar Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Amphastar Pharmaceuticals, Inc. (AMPH) compensation brief